Subclonal TP53 and KRAS Variants Combined with Poor Treatment Response Identify Ultra-High-risk Pediatric T-ALL PatientsTamara Kempter,Paulina Richter-Pechańska,Katarzyna Michel,Tobias Rausch,Büşra Erarslan-Uysal,Cornelia Eckert,Martin Zimmermann,Martin Stanulla,Martin Schrappe,Gunnar Cario, Stefan Köhrer,Andishe Attarbaschi,Jan O. Korbel,Joachim B. Kunz,Andreas E. KulozikBlood Advances（2025）引用 0|浏览0AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
